Intranasal and buccal midazolam in the treatment of acute seizures;Midazolam intranasal y bucal en el tratamiento de las convulsiones agudas

Revista de Neurologia

Volumn 38, Issue 5, 2004, Pages 458-468

  Armijo, Juan A ^a   Herranz, J L ^a   Pena Pardo, M A ^a   Adin J ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Acute seizures; Antiepileptic drugs; Buccal administration; Epilepsy; Intranasal administration; Midazolam

Indexed keywords

MIDAZOLAM; MIDAZOLAM MALEATE;

AMNESIA; ANTICONVULSANT ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EMERGENCY TREATMENT; HEART ARRHYTHMIA; HUMAN; NAUSEA; NOSE IRRITATION; RESPIRATION DEPRESSION; REVIEW; SEDATION; SEIZURE; VOMITING;

ADMINISTRATION, BUCCAL; ADMINISTRATION, INTRANASAL; ADULT; AEROSOLS; ANIMALS; ANTICONVULSANTS; CHILD; DRUG ADMINISTRATION ROUTES; HEART ARREST; HUMANS; HYDROGEN-ION CONCENTRATION; HYPNOTICS AND SEDATIVES; MIDAZOLAM; MUCOUS MEMBRANE; NERVOUS SYSTEM DISEASES; PATIENT ACCEPTANCE OF HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY INSUFFICIENCY; SAFETY; SEIZURES;

EID: 2342441059     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Dundee JW, Halliday NJ, Harper KW, Brogden RN. Midazolam: a review of its pharmacological properties and therapeutic use. Drugs 1984; 24: 519-43.
2. Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emergency Med 1997; 15: 357-65.
3. Blumer JL. Clinical pharmacology of midazolam in infants and children. Clin Pharmacokinet 1998; 1: 37-47.
4. Ficha técnica del Dormicum (01.04.1991). URL: http://sinaem.agemed. es:83/presentación/principal.asp. Fecha última consulta: 14.05.2003.
5. Crevoisier C, Ziegler W, Eckert M, Heizmann P. Relationship between plasma concentration and effect of midazolam after oral and intravenous administration. Br J Clin Pharmacol 1983; 16: 51-61.
6. Persson M, Nilsson A, Hartving P. Relation of sedation and amnesia to plasma concentrations of midazolam in surgical patients. Clin Pharmacol Ther 1988; 43: 324-31.
7. Coughlin MW, Panuska HJ. Direct comparison of midazolam and diazepam for conscious sedation in outpatient oral surgery. Anesth Prog 1989; 36: 150-68.
8. Wyant M, Diamond BI, O'Neal E, Sloan A. The use of midazolam in acutely agitated psychiatric patients. Psychopharmacol Bull 1990; 26: 126-9.
9. Cole SG, Brozinsky S, Isenberg JL. Midazolam, a new more potent benzodiazepine, compared with diazepam: a randomized, double-blind study of preendoscopic sedatives. Gastrointest Endosc 1983; 3: 219-22.
10. Zandsberg S, Rosenblaum M. Nonconventional drug administration in anaesthesia. Anesthesiol Clin North America 1994; 12: 17-38.
11. Streisand JB, Stanley TH. Newer drug delivery systems. Curr Anaesth Crit Care 1995; 6: 113-20.
12. Rey E, Delaunay L, Pons G, Murat I, Richard MO, Saint-Maurice C, et al. Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration. Eur J Clin Pharmacol 1991; 41: 355-7.
13. Walberg EJ, Wills RJ, Eckhert J. Plasma concentrations of midazolam in children following intranasal administration. Anesthesiology 1991; 74: 232-5.
14. Malinovsky JM, Lejus C, Servin F, Lepage JY, Le Normand Y, Testa S, et al. Plasma concentrations of midazolam after iv, nasal or rectal administration in children. Br J Anaesth 1993; 70: 617-20.
15. Rey E, Treluyer JM, Pons G. Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes. Clin Pharmacokinet 1999; 36: 409-24.
16. Bjorkman S, Rigerman G, Idvall J. Pharmacokinetics of midazolam given as an intranasal spray to adult surgical patients. Br J Anaesth 1997; 79: 575-80.
17. Allonen H, Ziegler G, Klotz U. Midazolam kinetics. Clin Pharmacol Ther 1981; 30: 653-61.
18. Heizmann P, Eckert M, Ziegler W. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol 1983; 16: 43-9.
19. Burstein AH, Modica R, Haston M, Forrest A, Gengo F. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol. 1997; 37: 711-8.
20. Henry RJ, Ruano N, Casto D, Wolf RH. A pharmacokinetic study of midazolam in dogs: nasal drop vs atomizer administration. Pediatr Dent 1998; 20: 321-6.
21. Wilton NCT, Leigh J, Rosen DR, Pandit UA. Preanaesthetic sedation of pre-school children using intranasal midazolam. Anesthesiology 1988; 69: 972-5.
22. Latson LA, Cheatham JP, Kugler JD, Danford DA, Hofschire PJ, Hotns J. Midazolam nose drops for outpatients echocardiography sedation in infants. Am Heart J 1991; 121: 209-10.
23. Kaufman E, Davidson E, Sheinkman Z, Magora F. Comparison between intranasal and intravenous midazolam sedation (with or without patient control) in a dental phobia clinic. J Oral Maxil Surg 1994; 52: 840-3.
24. Harcke HT, Grissom LE, Meister MA. Sedation in paediatric imaging using intranasal midazolam. Pediatr Radiol 1995; 84: 1429-31.
25. Hogberg L, Nordvall M, Tjellstrom B, Stenhammar L. Intranasal versus intravenous administration of midazolam to children undergoing small bowel biopsy. Acta Paediatr 1995; 84: 1429-31.
26. Malinovsky JM, Populaire C, Cotizan A, Lepage JY, Lejus C, Pinoud M. Premedication with midazolam in children. Effect of intranasal, rectal and oral routes on plasma midazolam concentrations. Anaesthesia 1995; 50: 351-4.
27. Lejus C, Renaudin M, Testa S, Malinovsky JM, Vigier T, Souron R. Midazolam for premedication in children: nasal vs rectal administration. Eur J Anaesth 1997; 14: 244-9.
28. Niall CT, Leigh J, Rosen DR, Pandit UA. Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology 1998; 69: 972-5.
29. Cheng ACK. Intranasal midazolam for rapidly sedating an adult patient. Anesth Analg 1993; 76: 904.
30. Fukuta O, Braham RL, Yanase H, Kurosu K. The sedative effects of intranasal midazolam administration in the dental treatment of patients with mental disabilities. Part 2: optimal concentration of intranasal midazolam. J Clin Pediatr Dent 1994; 18: 259-65.
31. Bates BA, Schutzman SA, Fleisher GR. A comparison on intranasal sufentanil and midazolam to intramuscular meperidine, promethazine, and chlorpromazine for conscious sedation in children. Ann Emerg Med 1994; 24: 646-51.
32. Knoester PD, Jonker DM, Van Der Hoeven RT, Vermeij TA, Edelbroek PM, Brekelmans GJ, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol 2002; 53: 501-7.
33. Harris AS, Nilsson IM, Wagner ZG, Alkner U. Intranasal administration of peptides: nasal deposition, biological response, and absorption of desmopressin. J Pharm Sci 1986; 75: 1085-8.
34. Loftsson T, Guomundsdottir H, Sigurjonsdottir JF, Sigurosson HH, Sigfusson SD, Masson M, et al. Cyclodextrin solubilization of benzodiazepines: formulation of midazolam nasal spray. Int J Pharm 2001; 212: 29-40.
35. Olivier JC, Djilani M, Fahmy S, Couet W. In situ nasal absorption of midazolam in rats. Int J Pharm 2001; 213: 187-92.
36. Gudmundsdottir H, Sigurjonsdottir JF, Masson M, Fjalldal O, Stefansson E, Loftsson T. Intranasal administration of midazolam in a cyclodextrin based formulation: bioavailability and clinical evaluation in humans. Pharmazie 2001; 56: 963-6.
37. Schwagmeir R, Alincic S, Striebel HW. Midazolam pharmacokinetics following intravenous and buccal administration. Br J Clin Pharmacol 1998; 46: 203-6.
38. Karl HW, Rosenberger JL, Larach MG, Ruffle JM. Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes. Anesthesiology 1993; 78: 885-91.
39. Fukuta O, Braham RL, Yanase H, Kurosu K. Intranasal Administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential. J Dent Child 1997; 64: 89-98.
40. Bailey PL, Pace NL, Ashburn MA, Moll JWB, East KA, Stanley TH. Frequent hipoxemia and apnea after sedation with midazolam and fentanyl. Anesthesiology 1990; 73: 826-30.
41. Lugo RA, Fishbein M, Nahata MC, Lininger B. Complication of intranasal midazolam. Pediatrics 1993; 92: 638.
42. Connors K, Temdrup TE. Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair. Ann Emerg Med 1994; 24: 1074-9.
43. Working Group of Status Epilepticus. Treatment of convulsive status epilepticus: recommendations of the epilepsy foundation of America's working group on status epilepticus. JAMA 1993; 270: 854-9.
44. Maytal J, Shinnar S, Moshe SL, Alvarez LA. Low morbidity and mortality of status epilepticus in children. Pediatrics 1989; 83: 323-31.
45. Hauser WA. Status epilepticus: epidemiologic considerations. Neurology 1990; 40: 9-13.
46. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia 1994; 35: 27-34.
47. Shorvon S. Status epilepticus: its clinical features and treatment in adults and children. Cambridge: Cambridge University Press; 1994.
48. DeLorenzo RJ, Pellock JM, Towne AR, Boggs JG. Epidemiology of status epilepticus. J Clin Neurophysiol 1995; 12: 316-25.
49. Lowenstein DH, Aldredge BK. Status epilepticus. N Engl J Med 1998; 338: 970-6.
50. Shorvon S. Tonic clonic status epilepticus. J Neurol Neurosurg Psychiatry 1993; 56: 125-34.
51. Lombroso CT. Intermittent home treatment of status and clusters of seizures. Epilepsia 1989; 30: 11-4.
52. Alldredge BK, Wall DB, Ferreiro DM. Effects of prehospital treatment on the outcome of status epilepticus in children. Pediatr Neurol 1995; 12: 213-6.
53. Scott R, Besag F, Neville B. Buccal midazolam and rectal diazepam for treatment of prolonged seizures in childhood and adolescence: a randomised trial. Lancet 1999; 353: 623-6.
54. Fisgin T, Gürer Y, Tezic T, Senbil N, Zorlu P, Okuyaz C, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol 2002; 17: 123-6.
55. Kanter RK, Zimmerman JJ, Strauss RH, Stoeckel KA. Pediatric emergency intravenous access. Am J Dis Child 1986; 140: 132-4.
56. Agurell S, Berlin A, Ferngren H. Plasma levels of diazepam after parenteral and rectal administration in children. Epilepsia 1975; 16: 277-83.
57. Remy C, Joudil N, Villemain D, Favel P, Genton P. Intrarectal diazepam in epileptic adults. Epilepsia 1992; 33: 353-8.
58. Dieckman RA. Rectal diazepam for prehospital pediatric status epilepticus. Ann Emerg Med 1994; 2: 216-24.
59. Dreifuss FN, Rosman P. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med 1998; 25: 1869-75.
60. O'Regan ME, Brown JK, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol 1996; 38: 1037-45.
61. Scheepers M, Scheepers B, Clough P. Midazolam via the intranasal route: an effective rescue medication for severe epilepsy in adults with a learning disability. Seizure 1998; 7: 509-12.
62. Jeannet PY, Roulet E, Maeder-Ingvar M, Gehri M, Jutzi A, Deonna T. Home and hospital treatment of acute seizures in children with nasal midazolam. Eur J Paediatr Neurol 1999; 3: 73-7.
63. Anonymous. Using medicines in school. Drugs Ther Bull 1994; 32: 81-3.
64. Scheepers M, Scheepers B, Clarke M, Comish S, Ibitoye M. Is intranasal midazolam an effective rescue medication in adolescents and adults with severe epilepsy? Seizure 2000; 9: 417-21.
65. Holmes GL. Buccal route for benzodiazepines in treatment of seizures? Lancet 1999; 353: 608-9.
66. Chattopadhyay A, Morris B, Blackburn L, Wassmer E, Whitehouse W. Buccal midazolam and rectal diazepam for epilepsy. Lancet 1999; 353: 1798.
67. Jawad S, Oxley J, Wilson J, Richens A. A pharmacodynamic evaluation of midazolam as an antiepileptic compound. J Neurol Neurosurg Psychiatry 1986; 9: 1050-4.
68. Galvin GM, Jelinek GA. Midazolam. An effective agent for seizure epilepsy control. Arch Emerg Med 1987; 8: 169-72.
69. Crisp CB, Gannon R, Knauft E. Continuous infusion of midazolarn hydrochloride to control status epilepticus. Clin Pharmacol 1988; 7: 332-4.
70. Kumar A, Bleck TP. Intravenous midazolam for the treatment of refractory status epilepticus. Crit Care Med 1992; 20: 483-8.
71. Lahat E, Alajdem M, Eshel G, Bistritzer T, Katz Y. Midazolam in treatment of epileptic seizures. Pediatr Neurol 1992; 8: 215-6.
72. Rivera R, Seguini M, Baltodano A, Pérez V. Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993; 21: 991-4.
73. Parent IM, Lowenstein OH. Treatment of refractory generalized status epilepticus with continuous infusion of midazolam. Neurology 1994; 44: 1837-40.
74. Roberts MR, Eng-Bourquin J. Status epilepticus in children. Emerg Med Clin North America 1995; 13: 489-507.
75. Chamberlain JM, Altieri MA, Futterman C, Young GM, Ochsenchlager DW, Waisman Y. A prospective randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care 1997; 13: 92-4.
76. Kendall J, Reynolds M, Goldberg R. Intranasal midazolam in patients with status epilepticus. Ann Emerg Med 1997; 29: 415-7.
77. Lahat E, Goldman M, Barr J, Eshel G, Berkovitch M. Intranasal midazolam for childhood seizures. Lancet 1998; 352: 620.
78. Fisgin T, Gürer Y, Tezic T, Zorlu P, Okuyaz C, Akgün D. Nasal midazolam effects on childhood acute seizures. J Child Neurol 2000; 15: 833-5.
79. Lahat E, Goldman M, Barr J, Bistritzer T, Berkovitch M. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. Br Med J 2000; 321: 83-6.
80. Harnden A. Intranasal midazolam for treating febrile seizures in children. Caution is required in applying hospital based evidence to primary care population. Br Med J 2001; 322: 108.
81. De Boer A, De Leede L, Breiner D. Drug absorption by sublingual and rectal routes. Br J Anaesth 1995; 56: 69-81.
82. Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2002; 41: 661-80.
83. Scott RC, Besag FM, Neville BG. Intranasal midazolam for treating febrile seizures in children. Buccal midazolam should be preferred to nasal midazolam. Brit Med J 2001; 322: 107.
84. Scott RC, Besag FM, Boyd SG, Berry D, Neville BG. Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia 1998; 39: 2904.
85. Scott RC, Neville BGR, Besag FMC, Boyd SG. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures. Dev Med Child Neurol 1997; 39: 137-8.
86. Phillips B, Appleton R. Intranasal midazolam for treating febrile seizures in children. Safety is as important as efficacy. BMJ 2001; 322: 107-8.
87. Ghilain S, Van Rijkevorsel-Harmant K, Harmant J, De Barsi TH. Midazolam in the treatment of epileptic seizures. J Neurol Neurosurg Psychiatry 1988; 51: 732.
88. Norris E, Marzouk O, Nunn A, McIntyre J, Choonara I. Respiratory depression in children receiving diazepam for acute seizures: a prospective study. Dev Med Child Neurol 1999; 41: 340-3.
89. Wallace SJ. Nasal benzodiazepines for management of acute childhood seizures? Lancet 1997; 349: 222.
90. Pramar YV, Loucas VA, El-Rachidi A. Stability of midazolam hydrochloride in syringes and IV fluids. Am J Health Syst Phann 1997; 54: 913-5.